1. Home
  2. PROP vs FDMT Comparison

PROP vs FDMT Comparison

Compare PROP & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROP
  • FDMT
  • Stock Information
  • Founded
  • PROP 2001
  • FDMT 2013
  • Country
  • PROP United States
  • FDMT United States
  • Employees
  • PROP 19
  • FDMT N/A
  • Industry
  • PROP Investment Bankers/Brokers/Service
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PROP Finance
  • FDMT Health Care
  • Exchange
  • PROP Nasdaq
  • FDMT Nasdaq
  • Market Cap
  • PROP 168.7M
  • FDMT 207.1M
  • IPO Year
  • PROP N/A
  • FDMT 2020
  • Fundamental
  • Price
  • PROP $3.97
  • FDMT $4.13
  • Analyst Decision
  • PROP Strong Buy
  • FDMT Buy
  • Analyst Count
  • PROP 4
  • FDMT 10
  • Target Price
  • PROP $8.75
  • FDMT $32.33
  • AVG Volume (30 Days)
  • PROP 839.6K
  • FDMT 432.1K
  • Earning Date
  • PROP 08-15-2025
  • FDMT 08-07-2025
  • Dividend Yield
  • PROP N/A
  • FDMT N/A
  • EPS Growth
  • PROP N/A
  • FDMT N/A
  • EPS
  • PROP N/A
  • FDMT N/A
  • Revenue
  • PROP $21,529,000.00
  • FDMT $23,000.00
  • Revenue This Year
  • PROP $5,974.95
  • FDMT $14,927.03
  • Revenue Next Year
  • PROP $26.36
  • FDMT N/A
  • P/E Ratio
  • PROP N/A
  • FDMT N/A
  • Revenue Growth
  • PROP N/A
  • FDMT N/A
  • 52 Week Low
  • PROP $3.35
  • FDMT $2.24
  • 52 Week High
  • PROP $12.30
  • FDMT $28.93
  • Technical
  • Relative Strength Index (RSI)
  • PROP 48.93
  • FDMT 54.45
  • Support Level
  • PROP $3.87
  • FDMT $4.21
  • Resistance Level
  • PROP $4.07
  • FDMT $4.62
  • Average True Range (ATR)
  • PROP 0.20
  • FDMT 0.30
  • MACD
  • PROP 0.03
  • FDMT -0.02
  • Stochastic Oscillator
  • PROP 50.88
  • FDMT 37.42

About PROP Prairie Operating Co.

Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: